Review finds 'paucity of robust evidence' on impact of AI clinical outcomes

AI-assisted tools have begun to make a mark on healthcare, with a 2020 study finding 64 FDA-approved devices and algorithms based on artificial intelligence and machine learning. Yet, the systematic review found a lack of evidence to support the technologies. "Despite the plethora of claims for the benefits of AI in enhancing clinical outcomes, there is a paucity of robust evidence. In this systematic review, we identified only a handful of RCTs comparing AI-assisted tools with standard-of-care management in various medical conditions," the authors wrote. Many of the 39 studies had limitations that affect the generalizability of their results.